You can buy or sell Aceto and other stocks, options, ETFs, and crypto commission-free!
Aceto Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. Read More The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY.
Port Washington, New York
52 Week High
52 Week Low
Advertising and Marketing
Present Technicals: Aceto Corporation (NASDAQ: ACET)
Aceto Corporation is part of the healthcare sector and is in the drug manufacturers industry. The company CEO is William C. Kennally. Aceto Corp is engaged in the marketing, sells and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, and specialty performance chemicals. Previous Intraday Trading Performance: The ACET stock showed a previous change of -1.39% with an open at 0.18 and a close of 0.18. It reached an intra...
Redington, Suven Life, CPPIB, Gourmet Investments in M&A news
In the latest M&A deals, Redington India on Friday said it has acquired 90 per cent stake in Auroma Logistics while Suven Life Sciences has entered into an asset purchase agreement to buy assets of Aceto Corporation’s Rising Pharmaceuticals and its subsidiaries.
Markets InsiderMar 7
ACETO Enters into “Stalking Horse” Agreement to Sell Rising Pharmaceuticals
PORT WASHINGTON, N.Y., March 07, 2019 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has entered into a “stalking-horse” asset purchase agreement with Shore Suven Pharma, Inc.
Expected Mar 29, After Hours